Atlas Trials

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Clinical trial NCT03092011 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03092011
Sponsor
The Cooper Health System
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Neonatal Abstinence Syndrome
Start date
2018-02-21
Primary completion
2024-10-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.